-65.7%
MRNA vs MTCH
-73.3%
+7.6%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MTCH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +4.8% |
| 7D | -1.1% | +1.3% | -2.4% | -1.6% |
| 30D | +126.1% | +15.9% | +110.2% | +114.6% |
| 3M | +190.0% | +23.3% | +166.8% | +169.2% |
| 6M | +157.2% | +40.1% | +117.1% | +127.9% |
| YTD | +388.2% | +33.6% | +354.6% | +338.1% |
| 1Y | +467.0% | +14.1% | +453.0% | +436.0% |
| 3Y | +36.1% | +1.4% | +34.7% | +29.2% |
| All | -65.7% | -73.3% | +7.6% | -59.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MTCH.
Daily Out/Under-Performance
Portfolio return minus MTCH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MTCH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MTCH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling